Integrative Metabolic Pathway Analysis Reveals Novel Therapeutic Targets in Osteoarthritis
Beatriz Rocha1, Berta Cillero-Pastor2, Gert Eijkel2
1Grupo de Investigación de Reumatología (GIR), Unidad de Proteómica, INIBIC - Complejo Hospitalario Universitario de A Coruña, SERGAS, Universidad de A Coruña, A Coruña, Spain.
Abstract:
In osteoarthritis (OA), impairment of cartilage regeneration can be related to a defective chondrogenic differentiation of mesenchymal stromal cells (MSCs). Therefore, understanding the proteomic- and metabolomic-associated molecular events during the chondrogenesis of MSCs could provide alternative targets for therapeutic intervention. Here, a SILAC-based proteomic analysis identified 43 proteins related with metabolic pathways whose abundance was significantly altered during the chondrogenesis of OA human bone marrow MSCs (hBMSCs). Then, the level and distribution of metabolites was analyzed in these cells and healthy controls by matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI), leading to the recognition of characteristic metabolomic profiles at the early stages of differentiation. Finally, integrative pathway analysis showed that UDP-glucuronic acid synthesis and amino sugar metabolism were downregulated in OA hBMSCs during chondrogenesis compared with healthy cells. Alterations in these metabolic pathways may disturb the production of hyaluronic acid (HA) and other relevant cartilage extracellular matrix (ECM) components. This work provides a novel integrative insight into the molecular alterations of osteoarthritic MSCs and potential therapeutic targets for OA drug development through the enhancement of chondrogenesis.
Insights
Osteoarthritis (OA) hinders cartilage repair due to defective mesenchymal stromal cells (MSCs) differentiation. This study reveals key metabolic pathway changes in OA MSCs, offering new therapeutic targets for enhancing cartilage regeneration.
Area of Science:
- Biochemistry
- Cell Biology
- Regenerative Medicine
Background:
- Osteoarthritis (OA) is characterized by impaired cartilage regeneration, often linked to defective chondrogenic differentiation of mesenchymal stromal cells (MSCs).
- Understanding the molecular mechanisms, particularly proteomic and metabolomic changes, during MSC chondrogenesis in OA is crucial for identifying therapeutic targets.
- Mesenchymal stromal cells (MSCs) are key to cartilage repair, and their dysfunction in OA impacts regenerative potential.
Purpose of the Study:
- To investigate the proteomic and metabolomic alterations during the chondrogenesis of human bone marrow MSCs (hBMSCs) from OA patients compared to healthy controls.
- To identify specific metabolic pathways and molecular events that are dysregulated in OA hBMSCs during chondrogenesis.
- To explore potential therapeutic targets for OA by understanding the molecular basis of defective chondrogenesis in OA MSCs.
Main Methods:
- Utilized SILAC-based proteomic analysis to identify differentially abundant proteins during chondrogenesis of OA hBMSCs.
- Employed matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI) to analyze metabolite levels and distribution.
- Performed integrative pathway analysis to connect proteomic and metabolomic data and identify dysregulated metabolic pathways.
Main Results:
- Identified 43 proteins associated with metabolic pathways that showed significant abundance changes during OA hBMSC chondrogenesis.
- Detected characteristic metabolomic profiles in early differentiation stages of OA hBMSCs.
- Found downregulation of UDP-glucuronic acid synthesis and amino sugar metabolism in OA hBMSCs during chondrogenesis compared to healthy controls.
Conclusions:
- Downregulation of specific metabolic pathways, including UDP-glucuronic acid synthesis and amino sugar metabolism, may impair hyaluronic acid (HA) and extracellular matrix (ECM) production in OA MSCs.
- These findings provide novel insights into the molecular alterations in osteoarthritic MSCs.
- The identified metabolic dysregulations represent potential therapeutic targets for enhancing chondrogenesis and developing new OA treatments.
Related Concept Videos
01:20The JAK-STAT Signaling Pathway
01:31Osteoclasts in Bone Remodeling